Ruby Gupta

Ruby Gupta practices at Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health.

Ruby Gupta's NPI, 1669707402, was assigned on October 13, 2009. Ruby Gupta holds Michigan license 4301506554.

Ruby Gupta's primary practice is Corewell Health Dearborn Hospital, at 18101 Oakwood Blvd, Dearborn, MI 48124 in Wayne County. The practice phone is (313) 593-7125.

Ruby Gupta's primary practice is Corewell Health Dearborn Hospital in Dearborn, Michigan, part of Corewell Health. Ruby Gupta is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Ruby Gupta to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ruby Gupta practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Ruby Gupta's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Ruby Gupta is licensed in Michigan.

CMS data shows 321 Medicare services from Ruby Gupta across 6 procedure codes in 2024, for 149 Medicare patients. Medicare paid $30,204 for them.

CMS counts 149 Medicare patients who saw Ruby Gupta in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ruby Gupta's median patient age at 67, with 72% women.

In 2024, Ruby Gupta wrote 767 Medicare Part D claims for 170 patients. 85% of them were for generic drugs. CMS names the drug for 580 of them, across 19 drugs with 11 or more claims each, at $575,463 in total drug cost. In 2023, CMS named 283 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Ruby Gupta for performance year 2024, reported as part of a group. Ruby Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ruby Gupta as offering telehealth.

Dmand AI links 33 papers to Ruby Gupta, published from 2014 to 2024. 2021 was the busiest year, with 10. The most frequent topics are Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols and Hyperthermia, Induced. Ruby Gupta has published most often in Clin Genitourin Cancer. Ruby Gupta's most frequent co-authors are Nwabundo Ifeyinwa Anusim, MD, Sachin Gupta, MD and Marianne T. Huben, DO.

CMS Open Payments shows 114 general payments to Ruby Gupta from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Genentech, Inc. paid the most, $278.